EndoBytes
A monthly summary of topical publications in Paediatric Endocrinology
Sponsored by Pfizer New Zealand
View previous EndoBytes reports View the latest EndoBytes report View an index to previous EndoBytes reports
EndoBytes


Welcome to EndoBytes a monthly newsletter and website which reviews brief commentary articles in Paediatric Endocrinology.

We have instituted a monthly review with brief commentary of 3 key articles in Paediatric Endocrinology that may have impact on clinical practice. This monthly review is entitled “EndoBytes” and is abbreviated to two pages. Articles are chosen from 20 journals that were published in the preceding one to two months in the Paediatric, General Medicine and Endocrinology fields.This is to ensure broad coverage of very current publications. Articles are selected that have relevance to clinical practice with a commentary that assists in utilising the information gleaned from the articles into shaping clinical practice.

The EndoBytes newsletter and website is generously supported by Pfizer New Zealand who have clearly demonstrated a commitment to Endocrinology CME. Although sponsored by Pfizer New Zealand, the selection of the publications and the commentaries are exclusively the responsibility and opinions of the authors. We hope you find the information in EndoBytes useful.

 
EndoBytes Authors

Wayne S Cutfield

Wayne S Cutfield

Paediatric Endocrinologist
Associate Professor in Paediatrics
Director of The Paykel Clinical Research Unit, Liggins Institute
Associate Director of the Liggins Institute
University of Auckland
Director of Endocrinology,
Starship Children’s Hospital
Auckland, New Zealand
 
 

Paul L Hofman

Paul L Hofman

Paediatric Endocrinologist
Senior Lecturer in Paediatrics
University of Auckland
Deputy Director of Endocrinology,
Starship Children’s Hospital
Auckland, New Zealand
Genotropin Datasheet for Clinicians The Liggins Institute

Genotropin Pen
The EndoBytes Newsletter and Website are sponsored through an unrestricted educational grant from Pfizer New Zealand to assist in the sharing of medical information relevant to the field of paediatric endocrinology. The views of the authors are not necessarily those of Pfizer New Zealand. EndoBytes has been developed to comply with regulatory requirements for distribution to clinicians who are resident in New Zealand.

Pfizer New Zealand